Sentinel lymph node biopsy for early stage vulvar squamous cell carcinoma
- PMID: 39712405
- PMCID: PMC11657103
- DOI: 10.1080/08998280.2024.2406696
Sentinel lymph node biopsy for early stage vulvar squamous cell carcinoma
Abstract
Background: Patients with regional lymph node involvement from squamous cell carcinoma (SCC) of the vulva have a 48% 5-year relative survival. Recently, sentinel lymph node (SLN) biopsy has become a viable alternative to inguinofemoral lymphadenectomy. We sought to identify risk factors for predicting a positive SLN in patients with vulvar SCC.
Methods: A retrospective review of 29 patients with vulvar SCC was performed from 2016 to 2021 at a tertiary care center. Clinicopathologic data were collected in addition to SLN status, including number of lymph nodes removed.
Results: The average depth of invasion was 7.9 mm, average tumor size was 1.8 cm, 3 of 23 patients had perineural invasion, and 4 of 23 patients had lymphovascular invasion. One patient who did not map on lymphoscintigraphy and five patients with recurrent vulvar SCC were excluded from final analysis. The average number of SLNs removed was two. One patient had a positive SLN: the depth of invasion was 17 mm, tumor size was 5.1 cm, and lymphovascular invasion was present.
Conclusions: Most patients with early stage vulvar SCC had a negative SLN biopsy. Further study is needed to determine the patient subset that could avoid SLN biopsy altogether.
Keywords: Lymphoscintigraphy; regional lymph nodes.
Copyright © 2024 Baylor University Medical Center.
Conflict of interest statement
The authors report no funding or conflicts of interest.
Figures
Similar articles
-
Sentinel lymph node biopsy procedure in squamous vulvar cancer. 10 years follow-up analysis.Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 Nov-Dec;39(6):360-366. doi: 10.1016/j.remn.2020.04.006. Epub 2020 Jun 17. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020. PMID: 32563714 English, Spanish.
-
Sentinel lymph node procedure in early-stage vulvar cancer: Correlation of lymphoscintigraphy with surgical outcome and groin recurrence.Eur J Surg Oncol. 2023 Oct;49(10):107006. doi: 10.1016/j.ejso.2023.107006. Epub 2023 Aug 3. Eur J Surg Oncol. 2023. PMID: 37572588
-
Phase II activity trial of high-dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: GROningen INternational Study on Sentinel nodes in Vulvar cancer III (GROINSS-V III/NRG-GY024).Int J Gynecol Cancer. 2023 Apr 3;33(4):619-622. doi: 10.1136/ijgc-2022-004122. Int J Gynecol Cancer. 2023. PMID: 36653060 Free PMC article. Clinical Trial.
-
Lymphoscintigraphy and sentinel lymph node biopsy in vulvar carcinoma: update from a European expert panel.Eur J Nucl Med Mol Imaging. 2020 May;47(5):1261-1274. doi: 10.1007/s00259-019-04650-8. Epub 2020 Jan 2. Eur J Nucl Med Mol Imaging. 2020. PMID: 31897584 Review.
-
Update on sentinel lymph node biopsy for early-stage vulvar cancer.Gynecol Oncol. 2015 Aug;138(2):472-7. doi: 10.1016/j.ygyno.2015.05.017. Epub 2015 May 27. Gynecol Oncol. 2015. PMID: 26022527 Review.
References
-
- SEER cancer statistics factsheets: vulvar cancer. Bethesda, MD: National Cancer Institute. https://seer.cancer.gov/statfacts/html/vulva.html. Accessed January 21, 2023.
-
- Cancer.net . ASCO: vulvar cancer. https://www.cancer.net/cancer-types/vulvar-cancer/introduction. Accessed January 23, 2023.
-
- National Comprehensive Cancer Network . Vulvar cancer (squamous cell carcinoma, version 1.2023). https://www.nccn.org/professionals/physician_gls/pdf/vulvar.pdf. Accessed August 26, 2023.
LinkOut - more resources
Full Text Sources
Research Materials